Ionis Pharmaceuticals (IONS) Intangibles (2010 - 2022)

Ionis Pharmaceuticals' Intangibles history runs 13 years deep, the most recent figure standing at $29.6 million for Q3 2022.

• On a quarterly basis, Intangibles fell 1.44% year-over-year to $29.6 million in Q3 2022; TTM through Sep 2022 was $29.6 million, a 1.44% decrease from a year earlier, with the FY2021 full-year figure at $29.0 million, up 3.82% from the prior year.
• Intangibles advanced to $29.6 million in Q3 2022 per IONS's latest filing, from $29.1 million in the prior quarter.
• Across five years, Intangibles topped out at $30.0 million in Q3 2021 and bottomed at $22.9 million in Q1 2018.
• The 5-year median for Intangibles is $27.7 million (2020), against an average of $27.1 million.
• Across the five-year window, Intangibles advanced 12.31% in 2019 and dropped 1.44% in 2022, its largest moves.
• Year by year, Intangibles stood at $24.0 million in 2018, then climbed by 6.83% to $25.7 million in 2019, then grew by 8.81% to $27.9 million in 2020, then rose by 3.82% to $29.0 million in 2021, then advanced by 2.07% to $29.6 million in 2022.
• Per Business Quant, the three latest IONS Intangibles figures stand at $29.6 million (Q3 2022), $29.1 million (Q2 2022), and $29.3 million (Q1 2022).